Determination of prospects of using “Sinuforte” drug in the current pharmacotherapy of sinusitis and the merchandising analysis of its package
Keywords:sinusitis, European cyclamen, lyophilized powder, Sinuforte, spray, merchandising analysis
AbstractMedicines in the form of sprays are the most suitable forms for treating respiratory diseases. The introduction of a clearly defined amount of the drug prevents the possibility of overdose and development of side effects. The drug Sinuforte created on the basis of the freeze-dried juice and the aqueous extract from fresh tubers of cyclamen is produced according to the standards of GMP, thus avoiding the bacteriological load. The mechanism of action of the drug is associated with activation of natural physiological processes of the nasal mucosa cleaning. The high clinical efficacy and safety have been proven by numerous clinical studies in advanced ENT clinics in more than 15 countries of the world. As a result of the study of Sinuforte the prospects of the drug use in the current pharmacotherapy of sinusitis have been determined; the compliance with the release specifications has been proven by conducting the merchandising analysis of the drug package.
Бесшапочный С.Б. // Ринология (Киев). − 2004. − № 3. − С. 63-67.
Гедеванишвили М.Д., Готидзе Н.М., Сихарулидзе И.С. // Вестник оториноларингологии. − 2007. − № 3. − С. 54-56.
Овчинникова А.Ю., Дженжера Г.Е., Лопатин А.С. // Вестн. оториноларингологии. − 2009. − № 5. − С. 54-57.
Петрова Л.Г. // Журнал ушных, носовых и горловых заболеваний. − 2004. − №2. − С. 85-87.
Янов Ю.К., Рязанцев С.В., Тимчук Л.Э. // Вестник оториноларингологии. − 2007. − № 4. − С. 49-51.
Bachert С., Schapowal A., Funk P. et al. // Rinology. − 2009. − Vol. 47, № 1. − P. 51-58.
Benhakroun Y., Zanin C., Bene M.C., Perruchet A.M. // Inter.Y.Immunopharm. − 1994. − Vol. 16, № 7. − P. 497-505.
Bornson D. B., Nadel LA. Regulation of airway secretion: role of peptides and proteases / Rhinitis and asthma // Ed. Myginol N., Pipkorn U., Dahl R. – Munkagaard: Copenhagen, 1990. − 183 p.
Dal Т., Onerci M., Caglar M. // Eur. Arch, otorhinolaryngol. − 1997. − Vol. 254, № 4. − P. 205-207.
Galen B.A. // Lippincotts Prim, care Pract. − 1997. − Vol. 1, № 2. − P. 183-198.
Pfaar O., Mullol J., Anders C., Hormann K., Klimek L. // Rhinology. − 2012. − Vol. 50, № 1. − P. 37-44.
Copyright (c) 2015 National University of Pharmacy
This work is licensed under a Creative Commons Attribution 4.0 International License.Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).